دورية أكاديمية

Increased production of inflammatory cytokines by circulating monocytes in mesial temporal lobe epilepsy: A possible role in drug resistance.

التفاصيل البيبلوغرافية
العنوان: Increased production of inflammatory cytokines by circulating monocytes in mesial temporal lobe epilepsy: A possible role in drug resistance.
المؤلفون: Milano, C.1 (AUTHOR) chiara.milano@phd.unipi.it, Montali, M.2 (AUTHOR), Barachini, S.2 (AUTHOR), Burzi, I.S.2 (AUTHOR), Pratesi, F.3 (AUTHOR), Petrozzi, L.1 (AUTHOR), Chico, L.1 (AUTHOR), Morganti, R.4 (AUTHOR), Gambino, G.2 (AUTHOR), Rossi, L.2 (AUTHOR), Ceravolo, R.1 (AUTHOR), Siciliano, G.1 (AUTHOR), Migliorini, P.5 (AUTHOR), Petrini, I.3 (AUTHOR), Pizzanelli, C.1 (AUTHOR) c.pizzanelli@ao-pisa.toscana.it
المصدر: Journal of Neuroimmunology. Jan2024, Vol. 386, pN.PAG-N.PAG. 1p.
مصطلحات موضوعية: *TEMPORAL lobe epilepsy, *EPILEPSY, *MONONUCLEAR leukocytes, *DRUG resistance, *IMMUNOCOMPETENT cells, *MONOCYTES
مستخلص: We analyzed peripheral blood mononuclear cells (PBMCs) and serum inflammatory biomarkers in patients with mesial temporal lobe epilepsy (drug-resistant – DR, vs. drug-sensitive – DS). Patients with epilepsy showed higher levels of serum CCL2, CCL3, IL-8 and AOPP, and lower levels of FRAP and thiols compared to healthy controls (HC). Although none of the serum biomarkers distinguished DR from DS patients, when analysing intracellular cytokines after in vitro stimulation, DR patients presented higher percentages of IL-1β and IL-6 positive monocytes compared to DS patients and HC. Circulating innate immune cells might be implicated in DR epilepsy and constitute potential new targets for treatments. [Display omitted] • Neuroinflammation may be fundamental for epileptogenesis and seizures' recurrence. • Peripheral immunocompetent cells may contribute to neuroinflammation in epilepsy. • Innate immune cells may be involved in drug resistance and represent new treatment targets. [ABSTRACT FROM AUTHOR]
قاعدة البيانات: Academic Search Index
الوصف
تدمد:01655728
DOI:10.1016/j.jneuroim.2023.578272